Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activityYang Wang, Yuhong Zhou|Antibody Therapeutics|2024Cited by 11
CD103<sup>+</sup>CD8<sup>+</sup> tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomesJianying Gu, Chuanyuan Wei, Junquan Song et al.|Clinical and Translational Medicine|2025Cited by 5
MDM2 inhibitors in sarcomas: results and next stepsIlaria Tortorelli, Robin L. Jones, Andrea Napolitano et al.|Current Opinion in Oncology|2025Cited by 2
Xrcc6 coordinates cardiomyocyte repair and immune regulation in myocardial ischemia-reperfusion injury: Fisetin as a therapeutic modulatorYijie He, Hongwen Xiao, Huan Yu et al.|Frontiers in Immunology|2025Cited by 2